Search results for "Chronic"

showing 10 items of 3309 documents

Expert opinion on managing chronic HCV in patients with cardiovascular disease

2018

International audience; Extrahepatic manifestations of chronic HCV infection include cardiovascular diseases and an increase in cardiovascular mortality. The pathogenic mechanisms by which HCV contributes to cardiovascular disease are not well defined, however, it is likely that systemic inflammation, and the promotion of other metabolic diseases are involved. In this Review, the evidence for HCV infection as a non-traditional risk factor for cardiovascular disease is evaluated. Furthermore, practical advice to evaluate cardiovascular disease risk and disease in chronic hepatitis C patients are included for help in daily clinical practice. Despite the advances in therapies for the treatment…

medicine.medical_specialtyCardiotonic AgentsHepacivirusDisease030204 cardiovascular system & hematologySystemic inflammationAntiviral Agents03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemRisk Factors[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesOdds RatioHumansMedicineDrug InteractionsPharmacology (medical)In patient030212 general & internal medicineRisk factorIntensive care medicineExpert TestimonyCardiovascular mortalityInflammationPharmacologybusiness.industryDisease progressionDisease ManagementHepatitis C Chronic3. Good healthInfectious DiseasesCardiovascular DiseasesExpert opinionPractice Guidelines as TopicDisease riskmedicine.symptombusiness
researchProduct

Special Considerations for Antihypertensive Agents in Dialysis Patients

2010

Hypertension is present in most patients with end-stage renal disease and likely contributes to the premature cardiovascular disease in dialysis patients. Previous practice guidelines have recommended that, in patients on chronic dialysis, blood pressure (BP) should be reduced below 130/80 mm Hg. This is based on opinions but not strong evidence, since no concrete information exists about which BP values should be the parameter to follow and which should be the target BP values. The majority of the antihypertensive agents can be used in this population, but the pharmacokinetics altered by the impaired kidney function and dialyzability influence the appropriate dosage as well as the time and…

medicine.medical_specialtyCardiotonic AgentsHypertension RenalCombination therapyMetabolic Clearance Ratemedicine.drug_classVasodilator Agentsmedicine.medical_treatmentAdrenergic beta-AntagonistsPopulationAngiotensin-Converting Enzyme InhibitorsCardiotonic AgentsRenal DialysisInternal medicinemedicineHumansDrug InteractionsDiureticseducationAntihypertensive drugAntihypertensive AgentsDialysisRandomized Controlled Trials as Topiceducation.field_of_studybusiness.industryHematologyGeneral MedicineCalcium Channel Blockersmedicine.diseaseEndocrinologyBlood pressureCardiovascular DiseasesNephrologyPractice Guidelines as TopicPolypharmacyKidney Failure ChronicDrug Therapy CombinationHemodialysisbusinessAngiotensin II Type 1 Receptor BlockersKidney diseaseBlood Purification
researchProduct

Update on the effects of graded motor imagery and mirror therapy on complex regional pain syndrome type 1: A systematic review.

2017

Graded motor imagery (GMI) and mirror therapy (MT) is thought to improve pain in patients with complex regional pain syndrome (CRPS) types 1 and 2. However, the evidence is limited and analysis are not independent between types of CRPS. The purpose of this review was to analyze the effects of GMI and MT on pain in independent groups of patients with CRPS types 1 and 2. Searches for literature published between 1990 and 2016 were conducted in databases. Randomized controlled trials that compared GMI or MT with other treatments for CRPS types 1 and 2 were included. Six articles met the inclusion criteria and were classified from moderate to high quality. The total sample was composed of 171 p…

medicine.medical_specialtyCausalgiaImagery PsychotherapyPopulationPhysical Therapy Sports Therapy and Rehabilitationlaw.invention03 medical and health sciences0302 clinical medicineMotor imageryPhysical medicine and rehabilitationRandomized controlled triallawmedicineHumansOrthopedics and Sports MedicineIn patient030212 general & internal medicineeducationPain Measurementeducation.field_of_studyMind-Body TherapiesRehabilitationChronic painmedicine.diseaseReflex Sympathetic DystrophyComplex regional pain syndromeMirror therapySample size determinationPhysical therapyPsychology030217 neurology & neurosurgeryComplex Regional Pain SyndromesJournal of back and musculoskeletal rehabilitation
researchProduct

Spectral Clustering Reveals Different Profiles of Central Sensitization in Women with Carpal Tunnel Syndrome

2021

Identification of subgroups of patients with chronic pain provides meaningful insights into the characteristics of a specific population, helping to identify individuals at risk of chronification and to determine appropriate therapeutic strategies. This paper proposes the use of spectral clustering (SC) to distinguish subgroups (clusters) of individuals with carpal tunnel syndrome (CTS), making use of the obtained patient profiling to argue about potential management implications. SC is a powerful algorithm that builds a similarity graph among the data points (the patients), and tries to find the subsets of points that are strongly connected among themselves, but weakly connected to others.…

medicine.medical_specialtyCentral sensitizationPhysics and Astronomy (miscellaneous)General Mathematicscarpal tunnel syndromegroupssensitization03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationComputer Science (miscellaneous)QA1-939MedicineCarpal tunnelpain030212 general & internal medicineLead (electronics)Carpal tunnel syndromespectral clusteringbusiness.industryChronic painDones Malaltiesmedicine.diseaseSpectral clusteringIntensity (physics)medicine.anatomical_structureChemistry (miscellaneous)Hyperalgesiamedicine.symptombusiness030217 neurology & neurosurgeryMathematics
researchProduct

Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus

2003

Chronic restraint stress has been shown to induce structural remodelling throughout the interconnected dentate gyrus-CA3 fields. To find out how this stressor affects the rate of adult hippocampal neurogenesis, we subjected rats to acute or chronic restraint stress and assessed the proliferation, survival and differentiation of newly born cells in the dentate gyrus. We also examined polysialylated neural cell adhesion molecule expression, a molecule normally expressed in immature neurons and important for morphological plasticity. The results show that acute restraint stress did not change either the proliferation of dentate gyrus precursor cells or the expression of polysialylated neural c…

medicine.medical_specialtyChemistryCell growthGeneral NeuroscienceDentate gyrusNeurogenesisHippocampal formationGranule cellEndocrinologymedicine.anatomical_structurePrecursor cellInternal medicinemedicineChronic stressNeural cell adhesion moleculeNeuroscienceEuropean Journal of Neuroscience
researchProduct

Molecular Remission Can Be Attained in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Follicular Lymphomas after Reduced Intensity Con…

2004

Abstract RIC followed by allo-SCT is an effective salvage treatment for some relapsed hematologic malignancies due to the postulated graft versus tumour (GVT) effect. In order to evaluate the quality of the clinical response, we have investigated the molecular status of patients receiving allo-SCT for relapsed disease. Forty-four patients (19 chronic lymphocytic leukemias (CLL), 21 follicular lymphomas (FCL) and 4 small lymphocytic lymphomas (SLL)) were enrolled in a prospective phase II study. The median age was 54 years (range: 32–69 years). The median number of previous chemotherapy regimens was 2 (range: 1–5) and 23% of patients had already failed an auto-SCT. Before transplant 34% of p…

medicine.medical_specialtyChemotherapyCyclophosphamidebusiness.industrymedicine.medical_treatmentChronic lymphocytic leukemiaImmunologyCell BiologyHematologyThioTEPAmedicine.diseaseBiochemistryGastroenterologyMinimal residual diseaseSurgeryFludarabineTransplantationimmune system diseaseshemic and lymphatic diseasesInternal medicinemedicineRefractory Chronic Lymphocytic Leukemiabusinessmedicine.drugBlood
researchProduct

Interferon for non-A, non-B chronic hepatitis

1991

Abstract We reviewed randomised clinical trials evaluating the effect of lymphoblastoid or recombinant α-interferon in non-A, non-B chronic hepatitis. The outcomes assessed were the rates of serum alanine aminotransferase normalization and relapse during and after stopping interferon. Data were pooled by meta-analysis and a 50% overall rate difference, favouring treated patients, was found. Results showed homogeneity in direction of treatment effect both after short-term (2–6 months, ≥ 2 mega-units thrice weekly) and long-term (9–18 months, variable dose) interferon course. Moreover, results did not change when type of publication (abstracts vs. full reports) and treatment duration or sched…

medicine.medical_specialtyChemotherapyHepatologybusiness.industrymedicine.medical_treatmentSurgeryClinical trialChronic hepatitisInterferonInternal medicineMeta-analysisMedicineDose reductionViral diseaseAlanine aminotransferasebusinessmedicine.drugJournal of Hepatology
researchProduct

Combination Treatment with Imatinib and Mitoxantrone/Etoposide Is a Suitable Preparative Regimen before Allogeneic Transplantation in Patients with M…

2005

Abstract In advanced BCR-ABL-positive leukemia, combination of chemotherapy with imatinib is expected to result in better reduction of leukemia cell load and may delay or offset clonal selection of resistant leukemia cells, thus improving the survival. We carried out a prospective phase I/II combination trial for patients (pts) with myeloid blast crisis of chronic myelogenous leukemia (CML). Pts were treated with imatinib+mitoxantrone/etoposide in four cohorts starting from mitoxantrone 10mg/m2/d and etoposide 100 mg/m2/d for 2 or 3 consecutive days and start of imatinib 600mg/d from day 15 (coh. 1 and 2) or from day 1 (coh. 3 and 4, respectively). After hematologic reconstitution following…

medicine.medical_specialtyChemotherapyMitoxantronebusiness.industrymedicine.medical_treatmentImmunologyMyeloid leukemiaCell BiologyHematologymedicine.diseaseBiochemistryGastroenterologyTransplantationImatinib mesylateInternal medicineCytarabineMedicinebusinessEtoposidemedicine.drugChronic myelogenous leukemiaBlood
researchProduct

Primary ciliary dyskinesia assessment by means of optical flow analysis of phase-contrast microscopy images

2014

Primary ciliary dyskinesia implies cilia with defective or total absence of motility, which may result in sinusitis, chronic bronchitis, bronchiectasis and male infertility. Diagnosis can be difficult and is based on an abnormal ciliary beat frequency (CBF) and beat pattern. In this paper, we present a method to determine CBF of isolated cells through the analysis of phase-contrast microscopy images, estimating cilia motion by means of an optical flow algorithm. After having analyzed 28 image sequences (14 with a normal beat pattern and 14 with a dyskinetic pattern), the normal group presented a CBF of 5.2 +/- 1.6 Hz, while the dyskinetic patients presented a 1.9 +/- 0.9 Hz CBF. The cutoff …

medicine.medical_specialtyChronic bronchitisPhase contrast microscopyOptical flowBeat (acoustics)Health InformaticsSensitivity and SpecificityPattern Recognition Automatedlaw.inventionTECNOLOGIA ELECTRONICAPrimary ciliary dyskinesialawOphthalmologyImage Interpretation Computer-AssistedMicroscopymedicineHumansMicroscopy Phase-ContrastRadiology Nuclear Medicine and imagingPrimary ciliary dyskinesiaMicroscopy VideoBronchiectasisRadiological and Ultrasound Technologybusiness.industryCiliumOptical flowActive contoursReproducibility of ResultsAnatomyImage Enhancementmedicine.diseaseComputer Graphics and Computer-Aided DesignCell TrackingSubtraction TechniqueFISICA APLICADABeat frequencyComputer Vision and Pattern RecognitionbusinessMATEMATICA APLICADAAlgorithmsFourier-Mellin transformCiliary Motility Disorders
researchProduct

Lipoma of the fossa femoralis mimicking a femoral hernia. Report of 2 cases

2018

Highlights • Femoral lipoma can be mistaken with femoral hernia. • Differential diagnosis between femoral lipoma and femoral hernia can result challenging. • The occurrence of femoral pain can lead to misinterpretation of the symptoms.

medicine.medical_specialtyChronic compressive damagesFossaDifferential diagnosiPhysical examinationAsymptomaticArticleChronic compressive damage03 medical and health sciences0302 clinical medicineFemoral maUltrasoundotorhinolaryngologic diseasesmedicinebiologymedicine.diagnostic_testbusiness.industryFemoral herniafungiUltrasoundfood and beveragesLipomabiology.organism_classificationmedicine.diseaseFemoral ringFemoral herniaSurgerybody regionsstomatognathic diseasesmedicine.anatomical_structureFemoral mass030220 oncology & carcinogenesisDifferential diagnosis030211 gastroenterology & hepatologySurgeryLipomaDifferential diagnosismedicine.symptombusinessInternational Journal of Surgery Case Reports
researchProduct